Literature DB >> 25872740

Development of a Newcastle disease virus vector expressing a foreign gene through an internal ribosomal entry site provides direct proof for a sequential transcription mechanism.

Zhenyu Zhang1,2, Wei Zhao2,3, Deshan Li1, Jinlong Yang2,4, Laszlo Zsak2, Qingzhong Yu2.   

Abstract

In the present study, we developed a novel approach for foreign gene expression by Newcastle disease virus (NDV) from a second ORF through an internal ribosomal entry site (IRES). Six NDV LaSota strain-based recombinant viruses vectoring the IRES and a red fluorescence protein (RFP) gene behind the nucleocapsid (NP), phosphoprotein (P), matrix (M), fusion (F), haemagglutinin-neuraminidase (HN) or large polymerase (L) gene ORF were generated using reverse genetics technology. The insertion of the second ORF slightly attenuated virus pathogenicity, but did not affect ability of the virus to grow. Quantitative measurements of RFP expression in virus-infected DF-1 cells revealed that the abundance of viral mRNAs and red fluorescence intensity were positively correlated with the gene order of NDV, 3'-NP-P-M-F-HN-L-5', proving the sequential transcription mechanism for NDV. The results herein suggest that the level of foreign gene expression could be regulated by selecting the second ORF insertion site to maximize the efficacy of vaccine and gene therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25872740     DOI: 10.1099/vir.0.000142

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Engineered Newcastle disease virus expressing the F and G proteins of AMPV-C confers protection against challenges in turkeys.

Authors:  Haixia Hu; Jason P Roth; Laszlo Zsak; Qingzhong Yu
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

Review 2.  Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology.

Authors:  Muhammad Bashir Bello; Khatijah Yusoff; Aini Ideris; Mohd Hair-Bejo; Abdurrahman Hassan Jibril; Ben P H Peeters; Abdul Rahman Omar
Journal:  Viruses       Date:  2020-04-16       Impact factor: 5.048

3.  Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs.

Authors:  Asuka Yoshida; Shin-Hee Kim; Vinoth K Manoharan; Berin P Varghese; Anandan Paldurai; Siba K Samal
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

Review 4.  Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy.

Authors:  Volker Schirrmacher; Stefaan van Gool; Wilfried Stuecker
Journal:  Biomedicines       Date:  2019-08-30

Review 5.  RNA Viruses as Tools in Gene Therapy and Vaccine Development.

Authors:  Kenneth Lundstrom
Journal:  Genes (Basel)       Date:  2019-03-01       Impact factor: 4.096

6.  Reverse Genetics of Newcastle Disease Virus.

Authors:  Stivalis Cardenas-Garcia; Claudio L Afonso
Journal:  Methods Mol Biol       Date:  2017

Review 7.  Newcastle disease vaccines-A solved problem or a continuous challenge?

Authors:  Kiril M Dimitrov; Claudio L Afonso; Qingzhong Yu; Patti J Miller
Journal:  Vet Microbiol       Date:  2016-12-16       Impact factor: 3.293

Review 8.  Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus.

Authors:  Qiuxing Meng; Jian He; Liping Zhong; Yongxiang Zhao
Journal:  Int J Med Sci       Date:  2021-03-30       Impact factor: 3.738

9.  Expression of Two Foreign Genes by a Newcastle Disease Virus Vector From the Optimal Insertion Sites through a Combination of the ITU and IRES-Dependent Expression Approaches.

Authors:  Lei He; Zhenyu Zhang; Qingzhong Yu
Journal:  Front Microbiol       Date:  2020-04-28       Impact factor: 5.640

Review 10.  Viral Vector-Based Melanoma Gene Therapy.

Authors:  Altijana Hromic-Jahjefendic; Kenneth Lundstrom
Journal:  Biomedicines       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.